Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEPHEN GERARD VINCENT

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1932221306
CMS profile
360659
Location
IDAHO FALLS, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,552.52

75 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,461.27 74
Education $91.25 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 75 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEPHEN GERARD VINCENT

NPI 1932221306 · CMS profile ID 360659

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

IDAHO FALLS, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 75 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932221306?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEPHEN GERARD VINCENT, NPI 1932221306, CMS profile ID 360659. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 75 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932221306?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). STEPHEN GERARD VINCENT, NPI 1932221306, CMS profile ID 360659. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 75 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932221306?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
STEPHEN GERARD VINCENT, NPI 1932221306, CMS profile ID 360659, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 75 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1932221306?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

75 matching records · $1,552.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 75 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 75.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $20.0612/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197559 CMS
AbbVie Inc. $8.6612/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437191 CMS
Biogen, Inc. $16.8912/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012268511 CMS
Novartis Pharmaceuticals Corporation $22.6611/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993413125 CMS
Eisai Inc. $22.4611/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333535 CMS
AbbVie Inc. $27.8611/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437185 CMS
Celgene Corporation $34.4211/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197477 CMS
AbbVie Inc. $9.7511/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437179 CMS
Celgene Corporation $24.3010/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197431 CMS
AbbVie Inc. $27.7410/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437173 CMS
Biogen, Inc. $15.7410/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012167085 CMS
Celgene Corporation $29.1710/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197377 CMS
AbbVie Inc. $19.2010/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437167 CMS
AbbVie Inc. $25.6309/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437163 CMS
Novartis Pharmaceuticals Corporation $19.1409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993413119 CMS
Celgene Corporation $18.3609/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197329 CMS
Merz Pharmaceuticals, LLC $29.1408/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048307075 CMS
GENZYME CORPORATION $20.5108/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049767977 CMS
Biogen, Inc. $28.7408/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012262109 CMS
AbbVie Inc. $15.3508/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437157 CMS
GENZYME CORPORATION $19.8608/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049767903 CMS
Genentech USA, Inc. $13.7308/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040563909 CMS
Celgene Corporation $20.1308/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197281 CMS
EMD Serono, Inc. $21.1708/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032312201 CMS
Celgene Corporation $6.0507/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197225 CMS
Celgene Corporation $3.6007/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197235 CMS
Genentech USA, Inc. $19.5207/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040563917 CMS
AbbVie Inc. $31.4107/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437151 CMS
Celgene Corporation $20.7607/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197215 CMS
Celgene Corporation $22.5907/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197201 CMS
Teva Pharmaceuticals USA, Inc. $91.2506/28/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056910129 CMS
Teva Pharmaceuticals USA, Inc. $16.7906/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056910167 CMS
AbbVie Inc. $28.2306/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437145 CMS
AbbVie Inc. $6.8306/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437139 CMS
Celgene Corporation $23.6206/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197185 CMS
AbbVie Inc. $26.6506/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437133 CMS
TG Therapeutics, Inc. $23.1806/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051484713 CMS
AbbVie Inc. $16.3706/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437127 CMS
ACADIA Pharmaceuticals Inc $17.5905/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053171075 CMS
Biogen, Inc. $16.6205/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012285581 CMS
AbbVie Inc. $12.2105/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437121 CMS
Celgene Corporation $29.5905/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197137 CMS
AbbVie Inc. $29.3705/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437115 CMS
AbbVie Inc. $12.7505/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437109 CMS
Genentech USA, Inc. $29.3505/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040563925 CMS
Celgene Corporation $6.8105/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197129 CMS
Neurelis, Inc. $22.1605/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050931241 CMS
Celgene Corporation $1.4904/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197059 CMS
Celgene Corporation $28.3004/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015197065 CMS
AbbVie Inc. $11.0804/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999437105 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $69,575.43 136
PY2020 $9,997.54 58
PY2021 $35,733.92 131
PY2022 $37,031.09 113
PY2023 $1,552.52 75
PY2024 $1,161.03 57
PY2025 $456.95 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Recipient $129.92 1
PY2019 Recipient $1,975.40 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient GENZYME CORPORATION $200.78 10/02/2019 Covered Recipient Physician An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-sponsored Studies of Alemtuzumab No dispute reported 06/30/2026 691584995
Recipient GENZYME CORPORATION $472.94 09/12/2019 Covered Recipient Physician A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) No dispute reported 06/30/2026 691568737
Recipient GENZYME CORPORATION $413.37 06/13/2019 Covered Recipient Physician An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-sponsored Studies of Alemtuzumab No dispute reported 06/30/2026 691553819
Recipient GENZYME CORPORATION $502.50 05/30/2019 Covered Recipient Physician A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) No dispute reported 06/30/2026 691551405
Recipient GENZYME CORPORATION $187.06 04/24/2019 Covered Recipient Physician A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) No dispute reported 06/30/2026 691551945
Recipient GENZYME CORPORATION $65.59 04/01/2019 Covered Recipient Physician A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) No dispute reported 06/30/2026 691553253
Recipient GENZYME CORPORATION $133.16 03/01/2019 Covered Recipient Physician A long-term follow up study for multiple sclerosis patients who have completed the alemtuzumab extension study No dispute reported 06/30/2026 691547675